Prescription drug · ANDA
Cyclobenzaprine Hydrochloride (cyclobenzaprine) NDC 76282-283
Cyclobenzaprine hydrochloride 10 mg/1 · Tablet · Oral · EXELAN PHARMACEUTICALS, INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 76282-283-10 | 76282028310 | 1000 TABLET in 1 BOTTLE (76282-283-10)Marketed from Apr 10, 2025 | |
| 76282-283-18 | 76282028318 | 180 TABLET in 1 BOTTLE (76282-283-18)Marketed from Apr 10, 2025 | |
| 76282-283-27 | 76282028327 | 270 TABLET in 1 BOTTLE (76282-283-27)Marketed from Apr 10, 2025 | |
| 76282-283-30 | 76282028330 | 30 TABLET in 1 BOTTLE (76282-283-30)Marketed from Apr 10, 2025 | |
| 76282-283-60 | 76282028360 | 60 TABLET in 1 BOTTLE (76282-283-60)Marketed from Apr 10, 2025 | |
| 76282-283-90 | 76282028390 | 90 TABLET in 1 BOTTLE (76282-283-90)Marketed from Apr 10, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cyclobenzaprine Hydrochloride
- Generic name (nonproprietary)
- cyclobenzaprine
- Active ingredients
- Cyclobenzaprine hydrochloride — 10 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- EXELAN PHARMACEUTICALS, INC.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090478
- Marketing start
- Listing expires
- Other FDA classes
- Centrally-mediated Muscle Relaxation (Physiologic effect)
- Identifiers
- Product ID 76282-283_19cb705f-c529-4ad4-8eda-3a3fd48feca7SPL ID 19cb705f-c529-4ad4-8eda-3a3fd48feca7SPL set ID cf81da00-7c6d-4477-bb70-b3c2abea177aRxCUI 828348UNII 0VE05JYS2PUPC 0376282283272, 0376282283104, 0376282283906, 0376282283609
- Pharmacologic class
- Muscle Relaxant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N476282028310followed by a unit qualifier and the quantityPackage 76282-0283-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Cyclobenzaprine hydrochloride tablets,USP are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living. Cyclobenzaprine hydrochloride should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific th…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 090478
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cyclobenzaprine Hydrochloridecyclobenzaprine | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | American Health Packaging | 60687-558 |
| Cyclobenzaprine Hydrochloridecyclobenzaprine | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | Northwind Health Company, LLC | 51655-973 |
| Cyclobenzaprine Hydrochloridecyclobenzaprine | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | NuCare Pharmaceuticals, Inc. | 68071-3150 |
| Cyclobenzaprine Hydrochloridecyclobenzaprine | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | NuCare Pharmaceuticals, Inc. | 68071-3154 |
| Cyclobenzaprine Hydrochloridecyclobenzaprine | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8084 |
| Cyclobenzaprine Hydrochloridecyclobenzaprine | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | Cipla USA Inc. | 69097-846 |
| Cyclobenzaprine Hydrochloridecyclobenzaprine | Cyclobenzaprine hydrochloride 5 mg/1 | Tablet, Film coatedOral | Cipla USA Inc. | 69097-845 |
| Cyclobenzaprine Hydrochloridecyclobenzaprine | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | Proficient Rx LP | 63187-812 |
| Cyclobenzaprine Hydrochloridecyclobenzaprine | Cyclobenzaprine hydrochloride 10 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-933 |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 5 mg/1 | Tablet, Film coatedOral | AvPAK | 50268-190 |
| Cyclobenzaprine Hydrochloridecyclobenzaprine | Cyclobenzaprine hydrochloride 10 mg/1 | Tablet, Film coatedOral | AvPAK | 50268-191 |